Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Aug 19, 2024 6:46pm
372 Views
Post# 36186882

Cancer free patients

Cancer free patientsI'm not sure if anyone has pointed this out but according to the new swimmer's plot there were:

2 patients still cancer free at 3 years after only one treatnent!
1 patient still cancer free at 2.5 years after only one treatnent!
1 patient still cancer free at 1.75 years after only one treatnent!
1 patient still cancer free at 1.25 years after only one treatnent!

So far all of our results have been obtained with no patient having had more than 2 treatments.

Clearly Ruvidar PDT is capable of completely eradicating NMIBC after only a single treatment. Why are some patients (about a third) not responding at all and why are some responders experiencing recurrence?

Not all of the patients who had no response or whose cancer recurred could have had upper urinary tract cancer. A substantial number probably had cancer cells which were deep enough below the surface of the urothelium that the green light did not reach them.

Theralase used green light, which has minimal penetration depth, to ensure there was no damage to the underlying healthy tissue.  I wonder if better overall results might not be possible in the future with further optimiztion - maybe with the judicious (targeted) use of deeper penetrating red light and the replacement of TLD1433 with Rutherrin,
<< Previous
Bullboard Posts
Next >>